|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1994-6-1
|
|
pubmed:abstractText |
To determine the efficacy of human lymphoblastoid interferon (L-IFN) in the treatment of compensated type C cirrhosis, 30 patients were assigned randomly to three groups, consisting of 10 patients each, who were treated as follows.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
89
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
681-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8172137-2',5'-Oligoadenylate Synthetase,
pubmed-meshheading:8172137-Aged,
pubmed-meshheading:8172137-Alanine Transaminase,
pubmed-meshheading:8172137-Female,
pubmed-meshheading:8172137-Hepacivirus,
pubmed-meshheading:8172137-Hepatitis Antibodies,
pubmed-meshheading:8172137-Hepatitis C,
pubmed-meshheading:8172137-Humans,
pubmed-meshheading:8172137-Interferon-alpha,
pubmed-meshheading:8172137-Liver Cirrhosis,
pubmed-meshheading:8172137-Male,
pubmed-meshheading:8172137-Middle Aged
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
A randomized, controlled trial of human lymphoblastoid interferon in patients with compensated type C cirrhosis.
|
|
pubmed:affiliation |
Second Department of Internal Medicine, Yamagata University School of Medicine, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
